Ginkgo Total Assets from 2010 to 2026

DNA Stock

USD 9.29 0.50 5.69%

Ginkgo Bioworks' Total Assets are increasing over the years with slightly volatile fluctuation. Overall, Total Assets are expected to go to about 1.7 B this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2020-12-31

Previous Quarter

1.2 B

Current Value

1.2 B

Quarterly Volatility

581.3 M

Covid

Interest Hikes

Check Ginkgo Bioworks financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ginkgo Bioworks' main balance sheet or income statement drivers, such as Net Interest Income of 46.5 M, Interest Income of 23 M or Depreciation And Amortization of 45.8 M, as well as many indicators such as Price To Sales Ratio of 2.45, Dividend Yield of 0.0 or PTB Ratio of 0.78. Ginkgo financial statements analysis is a perfect complement when working with Ginkgo Bioworks Valuation or Volatility modules.

Build AI portfolio with Ginkgo Stock

Check out the analysis of Ginkgo Bioworks Correlation against competitors.

Analyzing Ginkgo Bioworks's Total Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Total Assets has evolved provides context for assessing Ginkgo Bioworks's current valuation and future prospects.

Latest Ginkgo Bioworks' Total Assets Growth Pattern

Below is the plot of the Total Assets of Ginkgo Bioworks Holdings over the last few years. Total assets refers to the total amount of Ginkgo Bioworks assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ginkgo Bioworks Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Ginkgo Bioworks' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ginkgo Bioworks' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.38 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Ginkgo Total Assets Regression Statistics

	Arithmetic Mean	1,090,599,396
	Geometric Mean	968,497,572
	Coefficient Of Variation	54.98
	Mean Deviation	511,560,042
	Median	697,318,000
	Standard Deviation	599,665,327
	Sample Variance	359598.5T
	Range	1.9B
	R-Value	0.71
	Mean Square Error	192098.5T
	R-Squared	0.50
	Significance	0
	Slope	83,901,484
	Total Sum of Squares	5753576.1T

Ginkgo Total Assets History

	2026	1.7 B
	2025	1.6 B
	2024	1.4 B
	2023	1.7 B
	2022	2.5 B
	2021	2.1 B
	2020	675.2 M

Other Fundumenentals of Ginkgo Bioworks Holdings

Intangibles To Total Assets

Ginkgo Bioworks Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Long Term Debt Total	Capital Surpluse	Total Liab	Total Current Assets	Cash And Equivalents	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Invested Capital	Long Term Investments	Capital Stock	Net Working Capital	Deferred Long Term Liab	Short Term Investments
Total Assets		0.98	0.89	-0.41	-0.8	0.64	0.75	0.74	-0.65	0.84	0.91	0.91	0.91	0.73	0.86	0.16	0.79	0.83	0.98	-0.32	-0.01	0.89	0.32	0.31
Total Stockholder Equity	0.98		0.78	-0.56	-0.67	0.5	0.81	0.79	-0.51	0.71	0.8	0.97	0.97	0.59	0.75	0.3	0.65	0.82	1.0	-0.13	0.15	0.95	0.19	0.18
Net Tangible Assets	0.89	0.78		-0.15	-0.93	0.79	0.55	0.56	-0.77	0.98	0.97	0.7	0.69	0.82	0.91	-0.2	0.9	0.73	0.79	-0.67	-0.26	0.67	0.48	0.49
Net Debt	-0.41	-0.56	-0.15		-0.13	0.18	-0.81	-0.56	-0.38	0.01	-0.05	-0.7	-0.7	0.33	0.03	-0.7	0.16	-0.2	-0.51	-0.52	-0.72	-0.76	0.44	0.43
Retained Earnings	-0.8	-0.67	-0.93	-0.13		-0.81	-0.3	-0.46	0.92	-0.97	-0.94	-0.54	-0.54	-0.94	-0.93	0.42	-0.92	-0.76	-0.69	0.78	0.43	-0.5	-0.54	-0.53
Accounts Payable	0.64	0.5	0.79	0.18	-0.81		0.33	0.26	-0.72	0.77	0.81	0.39	0.37	0.78	0.74	-0.21	0.82	0.5	0.53	-0.71	-0.47	0.38	0.56	0.56
Net Receivables	0.75	0.81	0.55	-0.81	-0.3	0.33		0.53	0.0	0.39	0.5	0.9	0.89	0.16	0.34	0.58	0.29	0.36	0.8	0.09	0.25	0.94	-0.04	-0.04
Good Will	0.74	0.79	0.56	-0.56	-0.46	0.26	0.53		-0.43	0.53	0.57	0.7	0.71	0.33	0.67	0.36	0.5	0.84	0.76	0.14	0.58	0.73	-0.18	-0.18
Long Term Debt Total	-0.65	-0.51	-0.77	-0.38	0.92	-0.72	0.0	-0.43		-0.87	-0.85	-0.31	-0.31	-0.96	-0.92	0.48	-0.92	-0.76	-0.54	0.72	0.44	-0.25	-0.55	-0.54
Capital Surpluse	0.84	0.71	0.98	0.01	-0.97	0.77	0.39	0.53	-0.87		0.97	0.59	0.59	0.89	0.95	-0.33	0.94	0.75	0.72	-0.74	-0.34	0.55	0.53	0.53
Total Liab	0.91	0.8	0.97	-0.05	-0.94	0.81	0.5	0.57	-0.85	0.97		0.67	0.67	0.9	0.96	-0.15	0.96	0.77	0.81	-0.64	-0.31	0.64	0.51	0.52
Total Current Assets	0.91	0.97	0.7	-0.7	-0.54	0.39	0.9	0.7	-0.31	0.59	0.67		1.0	0.42	0.58	0.36	0.47	0.7	0.96	-0.04	0.2	0.99	0.12	0.1
Cash And Equivalents	0.91	0.97	0.69	-0.7	-0.54	0.37	0.89	0.71	-0.31	0.59	0.67	1.0		0.42	0.58	0.35	0.47	0.7	0.96	-0.03	0.21	0.99	0.12	0.1
Short Term Debt	0.73	0.59	0.82	0.33	-0.94	0.78	0.16	0.33	-0.96	0.89	0.9	0.42	0.42		0.9	-0.41	0.93	0.7	0.62	-0.75	-0.57	0.35	0.68	0.66
Intangible Assets	0.86	0.75	0.91	0.03	-0.93	0.74	0.34	0.67	-0.92	0.95	0.96	0.58	0.58	0.9		-0.19	0.97	0.85	0.76	-0.58	-0.21	0.54	0.44	0.44
Common Stock	0.16	0.3	-0.2	-0.7	0.42	-0.21	0.58	0.36	0.48	-0.33	-0.15	0.36	0.35	-0.41	-0.19		-0.22	-0.06	0.26	0.78	0.65	0.43	-0.5	-0.49
Property Plant Equipment	0.79	0.65	0.9	0.16	-0.92	0.82	0.29	0.5	-0.92	0.94	0.96	0.47	0.47	0.93	0.97	-0.22		0.71	0.67	-0.67	-0.38	0.44	0.53	0.54
Current Deferred Revenue	0.83	0.82	0.73	-0.2	-0.76	0.5	0.36	0.84	-0.76	0.75	0.77	0.7	0.7	0.7	0.85	-0.06	0.71		0.83	-0.26	0.14	0.65	0.28	0.26
Net Invested Capital	0.98	1.0	0.79	-0.51	-0.69	0.53	0.8	0.76	-0.54	0.72	0.81	0.96	0.96	0.62	0.76	0.26	0.67	0.83		-0.16	0.1	0.94	0.23	0.21
Long Term Investments	-0.32	-0.13	-0.67	-0.52	0.78	-0.71	0.09	0.14	0.72	-0.74	-0.64	-0.04	-0.03	-0.75	-0.58	0.78	-0.67	-0.26	-0.16		0.79	0.02	-0.7	-0.7
Capital Stock	-0.01	0.15	-0.26	-0.72	0.43	-0.47	0.25	0.58	0.44	-0.34	-0.31	0.2	0.21	-0.57	-0.21	0.65	-0.38	0.14	0.1	0.79		0.28	-0.71	-0.7
Net Working Capital	0.89	0.95	0.67	-0.76	-0.5	0.38	0.94	0.73	-0.25	0.55	0.64	0.99	0.99	0.35	0.54	0.43	0.44	0.65	0.94	0.02	0.28		0.01	0.0
Deferred Long Term Liab	0.32	0.19	0.48	0.44	-0.54	0.56	-0.04	-0.18	-0.55	0.53	0.51	0.12	0.12	0.68	0.44	-0.5	0.53	0.28	0.23	-0.7	-0.71	0.01		1.0
Short Term Investments	0.31	0.18	0.49	0.43	-0.53	0.56	-0.04	-0.18	-0.54	0.53	0.52	0.1	0.1	0.66	0.44	-0.49	0.54	0.26	0.21	-0.7	-0.7	0.0	1.0

Click cells to compare fundamentals

About Ginkgo Bioworks Financial Statements

Ginkgo Bioworks stakeholders use historical fundamental indicators, such as Ginkgo Bioworks' Total Assets, to determine how well the company is positioned to perform in the future. Although Ginkgo Bioworks investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ginkgo Bioworks' assets and liabilities are reflected in the revenues and expenses on Ginkgo Bioworks' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ginkgo Bioworks Holdings. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	1.6 B	1.7 B
Intangibles To Total Assets	0.05	0.03

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:

How To Invest In Ginkgo

Details

Is Ginkgo Stock a good investment?

Details

What is Ginkgo Bioworks' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Ginkgo Bioworks Correlation against competitors.

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. Projected growth potential of Ginkgo fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Ginkgo Bioworks assessment requires weighing all these inputs, though not all factors influence outcomes equally.

Earnings Share

(6.18)

Revenue Per Share

3.305

Quarterly Revenue Growth

(0.56)

Return On Assets

(0.16)

Return On Equity

(0.50)

Understanding Ginkgo Bioworks Holdings requires distinguishing between market price and book value, where the latter reflects Ginkgo's accounting equity. The concept of intrinsic value - what Ginkgo Bioworks' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Ginkgo Bioworks' price substantially above or below its fundamental value.

It's important to distinguish between Ginkgo Bioworks' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ginkgo Bioworks should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Ginkgo Bioworks' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Ginkgo Total Assets from 2010 to 2026

Latest Ginkgo Bioworks' Total Assets Growth Pattern

Ginkgo Total Assets Regression Statistics

Ginkgo Total Assets History

Other Fundumenentals of Ginkgo Bioworks Holdings

Ginkgo Bioworks Total Assets component correlations

About Ginkgo Bioworks Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY